Anthem Blue Cross Blue Shield of Colorado policy
MED.00146 Gene Therapy for Sickle Cell Disease
MED.00146 Gene Therapy for Sickle Cell Disease is a public Anthem Blue Cross Blue Shield of Colorado policy (policy MED.00146). It lists 5 CPT or HCPCS codes, 5 of them on the Anthem Blue Cross Blue Shield of Colorado prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- MED.00146
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of Colorado prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross Blue Shield of Colorado policies |
|---|---|---|---|
| 38206 | On the list | Blood-Derived Hematopoietic Progenitor Cell Harvesting, Transplantation/Collection; Autologous | Policies naming 38206 |
| 38232 | On the list | Bone Marrow Harvesting For Transplantation; Autologous | Policies naming 38232 |
| 38241 | On the list | Hematopoietic progenitor cell (HPC); autologous transplantation | Policies naming 38241 |
| J3392 | On the list | Injection, exagamglogene autotemcel, per treatment | Policies naming J3392 |
| J3394 | On the list | Injection, lovotibeglogene autotemcel, per treatment | Policies naming J3394 |
All Anthem Blue Cross Blue Shield of Colorado policies · Anthem Blue Cross Blue Shield of Colorado prior authorization CPT list